Science Explorer Back to mapMap
Discussion
Researcher · Sysmex (Germany) · Germany

Frank Holtrup

Frank Holtrup publishes mostly in Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations and Genetic factors in colorectal cancer.

OpenAlex
World rank
#3,409,665
of 7,710,434 ranked researchers
Rank in Germany
#170,163
of 364,343
Works
32
Citations
522
Citations per work
16.3
h-index
10
i10-index 10Top 60% in Cancer Research
Frank Holtrup

What does Frank Holtrup research?

Frank Holtrup's work is mostly in Biochemistry, Genetics and Molecular Biology (41%), Medicine (30%).

Life Sciences: 13 works · 41.1% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 41.1% of their workCancer Research: 7 works · 23.3% of their workMolecular Biology: 6 works · 17.8% of their workHealth Sciences: 10 works · 30.2% of their workMedicine: 10 works · 30.2% of their workPulmonary and Respiratory Medicine: 4 works · 11.0% of their workOncology: 3 works · 9.6% of their workPathology and Forensic Medicine: 2 works · 5.5% of their workPharmacology: 1 works · 4.1% of their workEverything else: 9 works · 28.7% of their workTHEIR WORKFrank Holtrup32works
Life Sciences41%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1341.1%
    1. Medicine1030.2%
  3. Everything else928.7%
  1. 1Cancer Research23% of their works
  2. 2Molecular Biology18% of their works
  3. 3Pulmonary and Respiratory Medicine11% of their works
  4. 4Oncology10% of their works
  5. 5Pathology and Forensic Medicine6% of their works
  6. 6Pharmacology4% of their works

Research topics

Which keywords describe Frank Holtrup's research?

The keywords of their largest research topics: Targeted Therapy, Cancer Genomics, Mutational Signatures, Clinical Trials, ALK Inhibitors, EGFR Mutations, Chemotherapy and Immunotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Targeted Therapy253 topics
  2. Cancer Genomics161 topic
  3. Mutational Signatures161 topic
  4. Clinical Trials92 topics
  5. ALK Inhibitors71 topic
  6. EGFR Mutations71 topic
  7. Chemotherapy63 topics
  8. Immunotherapy42 topics
  9. Microsatellite Instability41 topic
  10. Molecular Characterization41 topic
  11. Pharmacology31 topic
  12. Prenylated Flavonoids31 topic
  13. Cetuximab21 topic
  14. Garcinia Mangostana21 topic
  15. Genomic Profiles21 topic
  16. KRAS Mutations21 topic
  17. Pancreatic Cancer21 topic
  18. Small-Cell Lung Cancer21 topic
  19. St John's Wort21 topic
  20. Surgical Complications21 topic

Where does Frank Holtrup work?

Frank Holtrup's main affiliation in the publication record is Sysmex (Germany), Germany.

How many publications and citations does Frank Holtrup have?

OpenAlex counts 32 works and 522 citations for Frank Holtrup, an h-index of 10, ranking #3,409,665 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Frank Holtrup. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.